---
title: "Vigonvita Shareholders Unanimously Approve New H Share Award Scheme"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279806276.md"
description: "Vigonvita Shareholders Unanimously Approve New H Share Award Scheme"
datetime: "2026-03-19T14:10:15.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279806276.md)
  - [en](https://longbridge.com/en/news/279806276.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279806276.md)
---

# Vigonvita Shareholders Unanimously Approve New H Share Award Scheme

Vigonvita Shareholders Unanimously Approve New H Share Award Scheme

### Related Stocks

- [159506.CN](https://longbridge.com/en/quote/159506.CN.md)
- [516930.CN](https://longbridge.com/en/quote/516930.CN.md)
- [520880.CN](https://longbridge.com/en/quote/520880.CN.md)
- [159849.CN](https://longbridge.com/en/quote/159849.CN.md)
- [520690.CN](https://longbridge.com/en/quote/520690.CN.md)
- [510660.CN](https://longbridge.com/en/quote/510660.CN.md)
- [02630.HK](https://longbridge.com/en/quote/02630.HK.md)
- [512290.CN](https://longbridge.com/en/quote/512290.CN.md)
- [159992.CN](https://longbridge.com/en/quote/159992.CN.md)
- [516500.CN](https://longbridge.com/en/quote/516500.CN.md)
- [512010.CN](https://longbridge.com/en/quote/512010.CN.md)
- [159316.CN](https://longbridge.com/en/quote/159316.CN.md)
- [513700.CN](https://longbridge.com/en/quote/513700.CN.md)
- [159892.CN](https://longbridge.com/en/quote/159892.CN.md)
- [159837.CN](https://longbridge.com/en/quote/159837.CN.md)
- [588130.CN](https://longbridge.com/en/quote/588130.CN.md)
- [513060.CN](https://longbridge.com/en/quote/513060.CN.md)

## Related News & Research

- [Analyst Reiterates Buy on Microbix, Citing Temporary China Slowdown and Growing Diversified Demand](https://longbridge.com/en/news/286665358.md)
- [Everest Medicines Director and Major Shareholder Raises Stake in Company](https://longbridge.com/en/news/286481551.md)
- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [Visen Pharmaceuticals files HKEX return disclosing share repurchase at HKD 24.41 each](https://longbridge.com/en/news/287049299.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)